Nexviazyme 100 mg lyophilized powder for injection Images
Generic Name: avalglucosidase alfa
This medication has been identified as Nexviazyme 100 mg lyophilized powder for injection. It is supplied by Genzyme Corporation.
Nexviazyme is used in the treatment of Pompe Disease and belongs to the drug class lysosomal enzymes. Nexviazyme 100 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Nexviazyme
- Generic Name
- avalglucosidase alfa
- Strength
- 100 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Lysosomal enzymes
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genzyme Corporation
- National Drug Code (NDC)
- 58468-0426
See also:
Myozyme
Myozyme is used to treat a glycogen storage disorder called Pompe disease. Learn about side ...
Zavesca
Zavesca is used in the treatment of mild to moderate type 1 Gaucher disease. Learn about side ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Lumizyme
Lumizyme (alglucosidase alfa) is used to treat a glycogen storage disorder called Pompe disease ...
Pombiliti
Pombiliti (cipaglucosidase alfa-agta) is an intravenous infusion that is given over approximately 4 ...
More about Nexviazyme (avalglucosidase alfa)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: lysosomal enzymes
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.